Manufacturing

Articles

Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.

Catalent Invests $175 Million to Expand Manufacturing Capabilities and Capacity in US Facility

The renovations are expected to be completed by Feb. 1, 2021 and, upon completion, Aphena will move its corporate headquarters to the new location. 

Aphena Pharma Solutions Announces $21-Million Facility Expansion in Tennessee 

Educational sessions on the INTERPHEX show floor will include a panel discussion on implementing continuous manufacturing.

INTERPHEX 2019 Keynote Series Presents Panel Discussion on OSD Continuous Manufacturing

3D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities. 

INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma

Feliza Mirasol is the science editor for 

Small-molecule therapeutics can also benefit from the implementation of PAT in the manufacturing process.

PAT From a Small-Molecule Vantage Point

The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.

NJII and Rutgers University to Form the New Jersey Continuous Manufacturing Institute

A $5.5 billion acquisition brings Capsugel’s oral dosage delivery capabilities to Lonza’s portfolio. 

Lonza Completes Capsugel Acquisition

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Kathleen A. Estes, PhD, is director of research communications atBioPlan Associates, Inc. She is an experienced market research and data trends analyst, author, and editor, kestes@bioplanassociates.com.

Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.

Update on Continuous Bioprocessing: From the Industry’s Perception to Reality

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

Approval of breakthrough therapies requires expedited quality assessment.

Efficient Manufacturing Critical for Accelerated Drug Development

B. Thiyagarajan, PhD, is Group Leader, Biopharmaceutical at Avantor Performance Materials.

High-purity low-endotoxin sugars improve robustness and stability of protein formulation and improve drug product quality.

Manufacturing, Solid Dosage Drugs